Does Kaiser cover Mounjaro?
The Checkup by Singlecare
APRIL 24, 2025
It is approved by the Food and Drug Administration (FDA) for treating Type 2 diabetes. As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, it helps people manage their blood sugar levels. Mounjaro (tirzepatide) is a prescription drug developed by Eli Lilly.
52 
Let's personalize your content